34 min listen
COVID-19: Answering the Questions, Part 1
COVID-19: Answering the Questions, Part 1
ratings:
Length:
40 minutes
Released:
Jun 5, 2020
Format:
Podcast episode
Description
In this episode, Part 1 of an ongoing 12-part COVID-19 series, Vikramjit Mukherjee, MD, provides a brief update on the latest incidence trends, the role of serology in disease assessment, and newly published data from the ACTT-1 trial comparing remdesivir vs placebo for severe COVID-19 treatment. After the update, Dr. Mukherjee answers critical clinician questions on COVID-19 transmission, diagnosis, and management.Presenter:Vikramjit Mukherjee, MDDirector, Medical Intensive Care UnitBellevue HospitalAssistant ProfessorDivision of Pulmonary, Critical Care, and Sleep MedicineNYU School of MedicineNew York, New YorkContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Link to full program: https://bit.ly/3eDoJF0
Released:
Jun 5, 2020
Format:
Podcast episode
Titles in the series (100)
COVID-19: Answering the Questions, Part 7: In Part 7 of this ongoing 12-part COVID-19 series, listen to a brief update on COVID-19 risk and prevention strategies among healthcare workers by Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS. by CCO Infectious Disease Podcast